Health
Johnson & Johnson vaccine: Why it’s worth the minuscule risk – Inverse
The benefits for the one-dose Covid-19 vaccine outweigh the risks.
The CDC and the FDA lifted the pause
on the Johnson & Johnson Covid-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots.
Also, close monitoring of the J&J vaccine along with the Moderna and Pfizer vaccines that were given emergency use authorization will continue.
Dr. William Petri, an infectious disease physician and immunologist at the University of Virginia School of Medicine, explains…
-
General11 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News22 hours agoDeaths of Karen Edwards, Tim Thomson, and Gordon Twaddle re-examined in inquest
-
General23 hours agoThe Church of England’s ‘turning point’ to irrelevancy
-
General23 hours agoRobin Williams’s daughter begs fans to stop making AI content of her father